ChemGenex Phase I/IIa Study for Quinamed Shows How Genotypes Can Influence Dosing

Jun 13, 2007

Premium

The results of a Phase I/IIa dose-escalation study for ChemGenex’s investigational cancer drug Quinamed sheds light on how pharmacogenomics may be used to determine the right dose for patients.

The Phase I/IIa dose escalation study was designed to identify a genotypically optimized dose of Quinamed in heavily pre-treated patients with solid carcinomas. ChemGenex presented the results at the American Society of Clinical Oncology’s annual meeting last week in Chicago.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

All About the Proteins

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Lab Space and a Dream

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

"Must Stop"

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

This Week in Nucleic Acids Research

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.

Featured White Papers

Potential Pitfalls to Life Science Product Launch

Freeze-drying - a manufacturing approach to increase the stability of in vitro diagnostic (IVD) assays

Contract Manufacturing in Biotech: Turning Your Supply Chain Into a Competitive Differentiator

The Foundry Model is Coming to Molecular Diagnostics, Courtesy of the Semiconductor Industry

Nov

29

Featured Webinar

Glass or Polymer? A Comparison for Use in In Vitro Diagnostic Biochips

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.

Dec

04

Featured Webinar

Clinical-Grade Exome Analysis for Complex and Unsolved Case Investigations

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec

11

Featured Webinar

Assessing the Impact of Different Aneuploid Findings with Independent NGS Platforms

This webinar describes a study that used two independent next-generation sequencing (NGS) platforms to gain insight into the impact of different types of aneuploidies during preimplantation genetic testing.

Dec

12

Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

Main menu